Related references
Note: Only part of the references are listed.Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer
Naoko Matsuda et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications
Shiva Seyed Forootan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation
Guillermo Yoldi et al.
CANCER RESEARCH (2016)
RANKL/RANK control Brca1 mutation-driven mammary tumors
Verena Sigl et al.
CELL RESEARCH (2016)
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
Emma Nolan et al.
NATURE MEDICINE (2016)
Mast cells mediate malignant pleural effusion formation
Anastasios D. Giannou et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer
Endre Sebestyen et al.
NUCLEIC ACIDS RESEARCH (2015)
NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer
Collin M. Blakely et al.
CELL REPORTS (2015)
Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era
Anastasios Papanastasiou et al.
Current Molecular Pharmacology (2015)
RANK expression as a prognostic and predictive marker in breast cancer
Berit Maria Pfitzner et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Alternative splicing generates a truncated isoform of human TNFRSF11A (RANK) with an altered capacity to activate NF-κB
Chaido Sirinian et al.
GENE (2013)
Beneficial Impact of CCL2 and CCL12 Neutralization on Experimental Malignant Pleural Effusion
Antonia Marazioti et al.
PLOS ONE (2013)
RNA sequencing of cancer reveals novel splicing alterations
Jeyanthy Eswaran et al.
SCIENTIFIC REPORTS (2013)
RANK Induces Epithelial-Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis
Marta Palafox et al.
CANCER RESEARCH (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration
Anastasios D. Papanastasiou et al.
BREAST CANCER RESEARCH (2012)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling
Wei Tan et al.
NATURE (2011)
An EMT-Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
Irina M. Shapiro et al.
PLOS GENETICS (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Breast cancer precursors revisited: molecular features and progression pathways
Maria A. Lopez-Garcia et al.
HISTOPATHOLOGY (2010)
The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
Britta Weigelt et al.
JOURNAL OF PATHOLOGY (2010)
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
Eva Gonzalez-Suarez et al.
NATURE (2010)
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
Daniel Schramek et al.
NATURE (2010)
Histological and molecular types of breast cancer: is there a unifying taxonomy?
Britta Weigelt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes
L. Melchor et al.
ONCOGENE (2008)
Nuclear factor-κB activation:: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer
Sindhu Singh et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Epidermal growth factor receptor targeting in cancer
John Mendelsohn et al.
SEMINARS IN ONCOLOGY (2006)
Regulation of cancer cell migration and bone metastasis by RANKL
DH Jones et al.
NATURE (2006)
Epidermal growth factor receptor (EGFR) signaling in cancer
N Normanno et al.
GENE (2006)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics
M Lacroix et al.
ENDOCRINE-RELATED CANCER (2004)
NF-KB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
DK Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes
LWM Loo et al.
CANCER RESEARCH (2004)
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
A Kovalenko et al.
NATURE (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
